Herold Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$581K Hold
2,750
0.13% 160
2025
Q4
$565K Hold
2,750
0.13% 160
2025
Q3
$432K Hold
2,750
0.1% 170
2025
Q2
$462K Hold
2,750
0.1% 194
2025
Q1
$379K Buy
2,750
+150
+6% +$19.1K 0.08% 199
2024
Q4
$308K Hold
2,600
0.07% 216
2024
Q3
$287K Hold
2,600
0.06% 225
2024
Q2
$256K Hold
2,600
0.06% 231
2024
Q1
$291K Hold
2,600
0.07% 220
2023
Q4
$262K Hold
2,600
0.07% 209
2023
Q3
$226K Sell
2,600
-1,000
-28% -$90.4K 0.07% 222
2023
Q2
$340K Hold
3,600
0.1% 187
2023
Q1
$272K Hold
3,600
0.09% 196
2022
Q4
$277K Buy
3,600
+500
+16% +$38K 0.12% 168
2022
Q3
$206K Buy
+3,100
New +$197K 0.1% 178
2022
Q2
Sell
-2,950
Closed -$167K 256
2022
Q1
$167K Buy
+2,950
New +$158K 0.06% 219
2021
Q4
Sell
-3,350
Closed -$165K 261
2021
Q3
$165K Buy
+3,350
New +$182K 0.06% 221

Other funds holding CAH

Herold Advisors's CAH Position: Q1 2026 in Review

Herold Advisors held its Cardinal Health (CAH) position steady in Q1 2026 at 2,750 shares worth $581K. The position accounts for 0.13% of the portfolio, ranked #160.

Herold Advisors first reported a position in CAH in Q3 2021 and has held it in 17 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Herold Advisors held 2,750 shares of Cardinal Health worth $581K as of Q1 2026.
  • Herold Advisors left its Cardinal Health share count unchanged in Q1 2026.
  • Cardinal Health made up 0.13% of Herold Advisors's portfolio in Q1 2026, its #160 holding.
  • Herold Advisors first reported a position in Cardinal Health in Q3 2021 and has held it in 17 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Herold Advisors's 13F filing for Q1 2026, filed 15 May 2026.